MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Liu, Min Xia ^a,b   Zhou, Ke Cheng ^a,b   Cao, Yi ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Epithelial mesenchymal transition; Lung cancer; MCRS1; Metastasis; microRNA

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 129; MICROSPHERULE PROTEIN 1; OCCLUDIN; PROTEIN DSG2; PROTEIN ZO1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; 3' UNTRANSLATED REGION; MCRS1 PROTEIN, HUMAN; MIRN129 MICRORNA, HUMAN; NUCLEAR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL INVASION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; LUNG CANCER CELL LINE; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; MOLECULAR RECOGNITION; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SEQUENCE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METASTASIS; NUDE MOUSE; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE; TUMOR INVASION;

MUS MUSCULUS;

3' UNTRANSLATED REGIONS; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA-BINDING PROTEINS; UP-REGULATION;

EID: 84920867767     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-245     Document Type: Article

References (38)

1. Sato M, Shames DS, Gazdar AF, Minna JD: A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 1, 2:327-343. 10.1097/01.JTO.0000263718.69320.4c
2. Ding X-J, Liu M-X, Ao L, Liang Y-R, Cao Y: Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas. Virchows Arch 1, 458:561-569. 10.1007/s00428-011-1042-9
3. Liang Y-R, Liu M-X, Wang P, Ding X-J, Cao Y: Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall-cell lung cancer. Genes Chromosomes Canc 1, 52:305-315. 10.1002/gcc.22030
4. Ren Y, Busch RK, Perlaky L, Busch H: The 58-kDa microspherule protein (MSP58), a nucleolar protein, interacts with nucleolar protein p120. Eur J Biochem 1, 253:734-742. 10.1046/j.1432-1327.1998.2530734.x
5. Davidovic L, Bechara E, Gravel M, Jaglin XH, Tremblay S, Sik A, Bardoni B, Khandjian EW: The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons. Hum Mol Genet 1, 15:1525-1538. 10.1093/hmg/ddl074
6. Shimono K, Shimono Y, Shimokata K, Ishiguro N, Takahashi M: Microspherule protein 1, Mi-2β, and RET finger protein associate in the nucleolus and up-regulate ribosomal gene transcription. J Biol Chem 2005, 280:39436-39447. 10.1074/jbc.M507356200
7. Ivanova A, Ivanov S, Lerman M: Association, mutual stabilization, and transcriptional activity of the STRA13 and MSP58 proteins. Cell Mol Life Sci 1, 62:471-484. 10.1007/s00018-004-4423-2
8. Bader AG, Schneider ML, Bister K, Hartl M: TOJ1, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1). Oncogene 2001, 20:7524-7535. 10.1038/sj.onc.1204938
9. Okumura K, Zhao M, DePinho RA, Furnari FB, Cavenee WK: Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor. Proc Natl Acad Sci USA 1, 102:2703-2706. 10.1073/pnas.0409370102
10. Xu C-S, Zheng J-Y, Zhang H-L, Zhao H-D, Zhang J, Wu G-Q, Wu L, Wang Q, Wang W-Z, Zhang J: MSP58 Knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo. Asian Pac J Cancer Prev 1, 13:3233-3238. 10.7314/APJCP.2012.13.7.3233
11. Zhong M, Zhang X, Li B, Chen C-S, Ji G-L, Li S-X, Bi D-Q, Zhao Q-C, Shi H: Expression of MSP58 in hepatocellular carcinoma. Med Oncol 2013, 30:1-10.
12. Shi H, Chen S-X, Jin H-F, Xu C-S, Dong G-L, Zhao Q-C, Wang W-Z, Zhang H-W, Lin W, Zhang J: Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway. Cancer Sci 1, 100:1585-1590. 10.1111/j.1349-7006.2009.01223.x
13. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 1, 119:1420. 10.1172/JCI39104
14. Singh A, Settleman J: EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 1, 29:4741-4751. 10.1038/onc.2010.215
15. Chang H, Zhang C, Cao Y: Expression and distribution of symplekin regulates the assembly and function of the epithelial tight junction. Histochem Cell Biol 1, 137:319-327. 10.1007/s00418-011-0906-z
16. Amiri-Kordestani L, Basseville A, Kurdziel K, Fojo AT, Bates SE: Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resist Updates 1, 15:50-61. 10.1016/j.drup.2012.02.002
17. Yu Z, Pestell TG, Lisanti MP, Pestell RG: Cancer stem cells. Int J Biochem Cell Biol 1, 44:2144-2151. 10.1016/j.biocel.2012.08.022
18. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 1, 116:281-297. 10.1016/S0092-8674(04)00045-5
19. Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 1, 449:682-688. 10.1038/nature06174
20. Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N: MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 1, 10:1-9. 10.1186/1476-4598-10-1
21. Jiang S, Zhang H-W, Lu M-H, He X-H, Li Y, Gu H, Liu M-F, Wang E-D: MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 1, 70:3119-3127. 10.1158/0008-5472.CAN-09-4250
22. Ying Q, Liang L, Guo W, Zha R, Tian Q, Huang S, Yao J, Ding J, Bao M, Ge C: Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 1, 54:2064-2075. 10.1002/hep.24614
23. He Z, Cen D, Luo X, Li D, Li P, Liang L, Meng Z: Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor. Med Oncol 2013, 30:1-6.
24. Kong W, Yang H, He L, Zhao J-J, Coppola D, Dalton WS, Cheng JQ: MicroRNA-155 is regulated by the transforming growth factor β/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 1, 28:6773-6784. 10.1128/MCB.00941-08
25. Tsukita S, Furuse M, Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 1, 2:285-293. 10.1038/35067088
26. Li D, Mrsny RJ: Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J Cell Biol 1, 148:791-800. 10.1083/jcb.148.4.791
27. Cavallaro U, Christofori G: Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 2001, 1552:39-45.
28. Vinita W, Yogesh AK, Nikhil S, Amit KSG, Prasanna V: From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion. Biochem J 1, 447:61-70. 10.1042/BJ20111432
29. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 1, 7:131-142. 10.1038/nrm1835
30. Yu KR, Yang SR, Jung JW, Kim H, Ko K, Han DW, Park SB, Choi SW, Kang SK, Schöler H: CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 1, 30:876-887. 10.1002/stem.1052
31. Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D: A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 1, 71:6836-6847. 10.1158/0008-5472.CAN-11-0846
32. Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong W, Liao Y, Du J: High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer 2012, 49:604-615.
33. Johansson J, Berg T, Kurzejamska E, Pang M-F, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P: MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene 1, 32:5614-5624. 10.1038/onc.2013.322
34. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 1, 101:2999-3004. 10.1073/pnas.0307323101
35. Yu X, Luo L, Wu Y, Yu X, Liu Y, Yu X, Zhao X, Zhang X, Cui L, Ye G: Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol 2013, 30:1-6.
36. Brambilla E, Travis W, Colby T, Corrin B, Shimosato Y: The new World Health Organization classification of lung tumours. Eur Respir J 1, 18:1059-1068. 10.1183/09031936.01.00275301
37. Sobin LH, Fleming ID: TNM classification of malignant tumors. Cancer 1, 80:1803-1804. 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9
38. Dweep H, Sticht C, Pandey P, Gretz N: miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011,44(5):839-847. 10.1016/j.jbi.2011.05.002